GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Vitrolife AB (OSTO:VITR) » Definitions » Cyclically Adjusted Revenue per Share

Vitrolife AB (OSTO:VITR) Cyclically Adjusted Revenue per Share : kr15.72 (As of Mar. 2024)


View and export this data going back to 2001. Start your Free Trial

What is Vitrolife AB Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Vitrolife AB's adjusted revenue per share for the three months ended in Mar. 2024 was kr6.211. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is kr15.72 for the trailing ten years ended in Mar. 2024.

During the past 12 months, Vitrolife AB's average Cyclically Adjusted Revenue Growth Rate was 19.10% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 24.00% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 20.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Vitrolife AB was 24.00% per year. The lowest was 13.90% per year. And the median was 18.40% per year.

As of today (2024-06-02), Vitrolife AB's current stock price is kr184.70. Vitrolife AB's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was kr15.72. Vitrolife AB's Cyclically Adjusted PS Ratio of today is 11.75.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Vitrolife AB was 62.60. The lowest was 8.74. And the median was 25.27.


Vitrolife AB Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for Vitrolife AB's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vitrolife AB Cyclically Adjusted Revenue per Share Chart

Vitrolife AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.14 7.99 9.43 12.63 15.23

Vitrolife AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 13.20 13.96 14.53 15.23 15.72

Competitive Comparison of Vitrolife AB's Cyclically Adjusted Revenue per Share

For the Medical Devices subindustry, Vitrolife AB's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vitrolife AB's Cyclically Adjusted PS Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Vitrolife AB's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Vitrolife AB's Cyclically Adjusted PS Ratio falls into.



Vitrolife AB Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Vitrolife AB's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=6.211/132.2054*132.2054
=6.211

Current CPI (Mar. 2024) = 132.2054.

Vitrolife AB Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 1.305 100.432 1.718
201409 1.262 100.161 1.666
201412 1.261 100.225 1.663
201503 1.496 99.950 1.979
201506 1.696 99.995 2.242
201509 1.629 100.228 2.149
201512 1.833 100.276 2.417
201603 1.723 100.751 2.261
201606 1.914 101.019 2.505
201609 1.939 101.138 2.535
201612 2.311 102.022 2.995
201703 2.249 102.022 2.914
201706 2.629 102.752 3.383
201709 2.265 103.279 2.899
201712 2.495 103.793 3.178
201803 2.432 103.962 3.093
201806 2.609 104.875 3.289
201809 2.616 105.679 3.273
201812 2.949 105.912 3.681
201903 2.874 105.886 3.588
201906 3.507 106.742 4.344
201909 3.482 107.214 4.294
201912 3.772 107.766 4.627
202003 3.076 106.563 3.816
202006 1.927 107.498 2.370
202009 2.949 107.635 3.622
202012 3.523 108.296 4.301
202103 3.491 108.360 4.259
202106 3.519 108.928 4.271
202109 3.461 110.338 4.147
202112 4.142 112.486 4.868
202203 5.554 114.825 6.395
202206 6.123 118.384 6.838
202209 5.894 122.296 6.372
202212 6.315 126.365 6.607
202303 6.307 127.042 6.563
202306 6.684 129.407 6.829
202309 6.263 130.224 6.358
202312 6.684 131.912 6.699
202403 6.211 132.205 6.211

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


Vitrolife AB  (OSTO:VITR) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Vitrolife AB's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=184.70/15.72
=11.75

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Vitrolife AB was 62.60. The lowest was 8.74. And the median was 25.27.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Vitrolife AB Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of Vitrolife AB's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Vitrolife AB (OSTO:VITR) Business Description

Industry
Traded in Other Exchanges
Address
Box 9080, Gothenburg, SWE, 400 92
Vitrolife AB provides medical devices and genetic testing services intended for the reproductive-health market in the field of reproductive health. The company develops, manufactures, and distributes medical devices and provides genetic testing services for IVF clinics and their patients. Its mission is to support IVF clinics (in vitro fertilization) in enhancing their practice as well as the outcome of a patient's fertility treatment, thereby enabling patients to receive advanced support to navigate the complexities of reproductive health through successful outcomes and patient satisfaction.

Vitrolife AB (OSTO:VITR) Headlines

No Headlines